The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Formulations - EP4070787

The patent EP4070787 was granted to Gilead Sciences on Mar 1, 2023. The application was filed on Jun 29, 2016 under application number EP22176524A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4070787

GILEAD SCIENCES
Application Number
EP22176524A
Filing Date
Jun 29, 2016
Status
Granted And Under Opposition
Jan 27, 2023
Publication Date
Mar 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ZENTIVANov 29, 2023REDDIE & GROSEADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0208241
DESCRIPTIONWO03016306
DESCRIPTIONWO2013025788
OPPOSITIONEP1583542
OPPOSITIONUS2007077295
OPPOSITIONWO2013025788
SEARCHWO2013116720
SEARCHWO2015022351
SEARCHWO2015196116

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents